With approximately $2.3 billion in facility-specific investment and 489 permanent operating jobs announced, this project clears both of AFT's qualifying thresholds ($100 million in facility-specific investment OR 100 permanent operating jobs). It is also confirmed by official public sources and involves a physical manufacturing facility in the United States.
View full methodology →The pharmaceuticals context.
Pharmaceutical manufacturers are committing billions to new U.S. production capacity for active ingredients, injectable medicines, biologics and other high-demand treatments. North Carolina and Indiana remain major centers of investment, while new facilities are being planned across the South. The current project pipeline includes both large greenfield campuses and major expansions of established production sites.
At a glance
- Company
- Bristol Myers Squibb
- Industry
- Pharmaceuticals
- Location
- Houston, Texas
- Investment
- Approximately $2.30B
- Permanent jobs announced
- 489
- Status
- Planning
- Announced
- Aug 10, 2026
- Opening timeline
- Not yet announced
- Added to tracker
- Sep 1, 2026
Official references
- BMS's August 10, 2026 Houston campus announcement https://news.bms.com/news/corporate-financial/2026/Bristol-Myers-Squibb-Advances-U-S--Manufacturing-Investment-with-New-2-3-Billion-Campus-in-Houston-Texas/default.aspx
Cite this project
American Factory Tracker. "Generation Park Multi-Modal Manufacturing Campus — Bristol Myers Squibb, Houston, TX." https://americanfactorytracker.com/projects/bristol-myers-squibb-generation-park-houston. Accessed November 3, 2026.
Please also cite the original sources listed above for underlying figures.